期刊文献+

波立维和泰嘉在冠心病治疗中的疗效和经济学对比分析 被引量:7

Wave Vertical Peacekeeping Tai Jia in Efficacy in the Treatment of Coronary Heart disease(CHD) and Contrast Analysis of Economics
下载PDF
导出
摘要 目的分析对比波立维和泰嘉治疗冠心病的临床疗效及经济学差异。方法选取2013年3月—2014年5月期间该院收治的冠心病患者80例,随机分为波立维组及泰嘉组。对比分析两组患者的临床疗效、不良反应以及患者的治疗费用。结果在随访1年内,两组患者的临床有效率及不良反应发生情况差异无统计学意义(P>0.05);泰嘉组的治疗费用明显低于波立维组,两组差异具有统计学意义(P<0.05)。结论临床运用波立维及泰嘉治疗冠心病在临床疗效、不良反应基本无区别,但泰嘉的治疗费用明显低于波立维。所以可以用泰嘉代替波立维代替治疗冠心病。 Objective To analyzed wave set peacekeeping tai jia difference in economics and the clinical curative effect of treatment of coronary heart disease (CHD).Methods Between March 2013 and May 2013 in our department to take the 80 cases of patients with coronary heart disease, were randomly divided into wave d and tai jia group. Comparative analysis of two groups of patients with clinical efficacy, adverse reactions, and the patient’s treatment.Results In the follow-up of 1 year, two groups of patients with the clinical effectiveness and adverse reactions occur differences had no statistical significance (P〉 0.05); But the costs of treating tai jia group was obviously lower wavelengths, d group, the differences between the two groups have statistical significance (P〈 0.05).Conclusion The clinical use of wave vertical dimension and tai jia on the treatment of coronary heart disease in clinical efficacy, So you can use tai jia for wave vertical dimension for treatment of coronary heart disease.
作者 赵春军
出处 《中外医疗》 2015年第9期133-134,共2页 China & Foreign Medical Treatment
关键词 波立维 泰嘉 冠心病 临床疗效 Wave d Tai jia Coronary heart disease Clinical curative effect
  • 相关文献

参考文献6

二级参考文献20

  • 1Gergely Feher,Andrea Feher,Gabriella Pusch,Katalin Koltai,Antal Tibold,Beata Gasztonyi,Elod Papp,Laszlo Szapary,Gabor Kesmarky,Kalman Toth.Clinical importance of aspirin and clopidogrel resistance[J].World Journal of Cardiology,2010,2(7):171-186. 被引量:36
  • 2朱永锋,李继福,李贵双,李静,张娣,朱媛媛,陈文强.国产和进口氯吡格雷对不稳定性心绞痛患者血小板功能的影响[J].中华老年心脑血管病杂志,2004,6(6):377-379. 被引量:19
  • 3张鉴,彭向前,李军.质子泵抑制剂的代谢与细胞色素P450[J].山东医药,2005,45(20):64-65. 被引量:13
  • 4李志娟,方新历,董平栓,杨旭明.冠状动脉介入治疗术对冠心病患者血小板功能的影响[J].中国煤炭工业医学杂志,2006,9(9):923-924. 被引量:4
  • 5The CURE Investigators.Effects of clopidogrel in addition to aspirin in atients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345(7):494-502.
  • 6Jaremo P,Lindahl T,Fransson S,et al.Individual variations of platelet inhibition after loading doses of clopidogrel[J].J Intern Med,2002,252:233-238.
  • 7Gurbel P,Bliden K,Hiatt B,et al.Clopidogrel for coronary stenting:response variability,drug resistance,and the effect of pretreatment platelet reactivity[J].Circulation,2003,107:2908-2913.
  • 8Muller I,Besta F,Schulz C,et al.Prevallence of Clopidogrel non-reponders among patients with stable angina pectoris scheduled for elective coronary steng placement[J].Thromb Haemost,2003,89:783-787.
  • 9Wei C,Lau,Paul A.Gurbel.The drug-drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180(7):699-700.
  • 10David N,Juurlink MD PhD,Tara Gomes MHSc,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,80(7):713-718.

共引文献67

同被引文献34

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部